Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 7, 2025; 31(9): 101383
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.101383
Figure 5
Figure 5 The decision curve analysis of the Extreme Gradient Boosting model, Extreme Gradient Boosting + liver stiffness measurement model, aspartate aminotransferase to platelet ratio index score and Fibrosis index based on the 4 factors score. A: Training cohort; B: Validation cohort. The Extreme Gradient Boosting models showed better net benefits than the aspartate aminotransferase to platelet ratio index score and Fibrosis index based on the 4 factors score. DCA: Decision curve analysis; APRI: Aspartate aminotransferase to platelet ratio index; FIB-4: Fibrosis index based on the 4 factors; LSM: Liver stiffness measurement; XGBoost: Extreme Gradient Boosting.